Scar treatment products aim to reduce the appearance of scars resulting from injuries or surgeries by making them less visible or noticeable. These include creams, gels, sheets, laser therapy devices and others that help improve the texture and color of scars to make the skin appearance even. The growing number of road accidents and surgical procedures has increased the demand for scar treatment in China.
The China Scar Treatment Market is estimated to be valued at US$ 16.59 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increase in the medical tourism industry: The availability of advanced yet cheaper medical treatments and aesthetic procedures has boosted medical tourism in China. Many foreigners travel to China for scar revision surgeries and treatments. This has positively impacted the demand for scar treatment products.
Rising adoption of laser therapy devices: Laser therapy devices such as fractional CO2 laser, pulse dye laser and ablative lasers are gaining popularity for scar reduction procedures. The accuracy and effectiveness of laser treatments in minimizing scar appearance without major side effects is driving their adoption. Various products combining laser with radiofrequency and other technologies are introduced to get better cosmetic outcomes.
Growing e-commerce platforms: E-commerce platforms offering a wide range of scar treatment creams, gels, sheets and other products directly at the customer’s doorstep are increasing rapidly in China. The rising number of online shoppers preferring convenience and variety of options is boosting the sales of scar treatments through digital platforms.
Strength: The China scar treatment market has a large population base that experiences trauma and injuries, leading to scarring. There is increased awareness about scar treatment products and procedures in the country.
Weakness: High costs associated with certain laser scar removal procedures can limit their adoption in China. Lack of reimbursements for scar treatments under medical insurance is also a weakness.
Opportunity: Growing medical tourism in China offers scope for cosmetic surgeons and dermatologists to promote scar revision procedures. The rising focus on aesthetics and appearance enhancement provides opportunities.
Threats: Presence of counterfeit scar treatment products poses safety issues. Strict regulations and compliance norms for new product approvals can delay market entry.
The China Scar Treatment Market Size is expected to witness high growth, exhibiting CAGR of 13% over the forecast period, due to increasing awareness about treatment and prevention of scarring and rising focus on aesthetics.
The China region dominates the scar treatment market in the Asia Pacific due to large patient pool, growing medical tourism, rising cosmetic procedures and increasing access to healthcare. Within China, South Eastern provinces have emerged as major markets for scar treatments driven by higher disposable incomes and spending on personal care.
Key players operating in the China scar treatment market are Smith & Nephew plc, Merz, Inc., Lumenis, Enaltus LLC, Sonoma Pharmaceuticals, Inc., Mölnlycke Health Care, Cynosure, Inc., CCA Industries, Inc., Scarheal, Inc., NewMedical Technology, Inc., and Suneva Medical, Inc. Product innovation, geographical expansion and strategic mergers and acquisitions are key strategies adopted by these players to strengthen their market position.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it